Candidate genes for the progression of malignant gliomas identified by microarray analysis
- 5 October 2007
- journal article
- Published by Springer Science and Business Media LLC in Neurosurgical Review
- Vol. 31 (1), 83-90
- https://doi.org/10.1007/s10143-007-0107-3
Abstract
Malignant astrocytomas of World Health Organization (WHO) grade III or IV have a reduced median survival time, and possible pathways have been described for the progression of anaplastic astrocytomas and glioblastomas, but the molecular basis of malignant astrocytoma progression is still poorly understood. Microarray analysis provides the chance to accelerate studies by comparison of the expression of thousands of genes in these tumours and consequently identify targeting genes. We compared the transcriptional profile of 4,608 genes in tumours of 15 patients including 6 anaplastic astrocytomas (WHO grade III) and 9 glioblastomas (WHO grade IV) using microarray analysis. The microarray data were corroborated by real-time reverse transcription-polymerase chain reaction analysis of two selected genes. We identified 166 gene alterations with a fold change of 2 and higher whose mRNA levels differed (absolute value of the t statistic of 1.96) between the two malignant glioma groups. Further analyses confirmed same transcription directions for Olig2 and IL-13Rα2 in anaplastic astrocytomas as compared to glioblastomas. Microarray analyses with a close binary question reveal numerous interesting candidate genes, which need further histochemical testing after selection for confirmation. IL-13Rα2 and Olig2 have been identified and confirmed to be interesting candidate genes whose differential expression likely plays a role in malignant progression of astrocytomas.Keywords
This publication has 38 references indexed in Scilit:
- Gene Expression Profile of Glioblastoma Multiforme Invasive Phenotype Points to New Therapeutic TargetsNeoplasia, 2005
- Gene Expression Profiling of Gliomas Strongly Predicts SurvivalCancer Research, 2004
- The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human GliomasJournal of Clinical Oncology, 2004
- The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse GliomasJournal of Neuropathology and Experimental Neurology, 2004
- Characterization of Gene Expression Profiles Associated with Glioma Progression Using Oligonucleotide-Based Microarray Analysis and Real-Time Reverse Transcription-Polymerase Chain ReactionThe American Journal of Pathology, 2003
- Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical ResultsJournal of Clinical Oncology, 2003
- Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesGenome Biology, 2002
- An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene ExpressionMethods, 2001
- The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13–induced signal transduction through the STAT6 pathwayBlood, 2001
- Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis AntigenMolecular Medicine, 2000